Filing Details

Accession Number:
0001144204-19-029723
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-06-04 16:22:02
Reporting Period:
2019-05-31
Accepted Time:
2019-06-04 16:22:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
3116 Akorn Inc AKRX Pharmaceutical Preparations (2834) 720717400
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1386609 D Alan Weinstein C/O Akorn, Inc.
1925 W. Field Court, Suite 300
Lake Forest IL 60045
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-31 50,000 $3.97 161,555 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 20,200 Indirect By Spouse
Footnotes
  1. Following the reported transaction, the amount of shares beneficially owned includes 46,610 unvested RSUs and 114,945 shares owned outright.